Key result
Chronic administration of ouabain in Wistar rats significantly increased resting mean arterial pressure compared to controls (111 vs 93 mm Hg; P<0.05), which was prevented by concomitant losartan.
Why the study?
Does central administration of losartan prevent ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats?
Population
Wistar rats
Comparison
Subcutaneous ouabain and intracerebroventricular… vs Control rats and rats treated with subcutaneous…
Design
Preclinical
Follow-up
15 days
Authors
Loading...
Supports brain RAS role in sympathetic hypertension models; leaves open translation to human therapy.
Does central administration of losartan prevent ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats?
Absolute Event Rate: 111% vs 93%
p-value: p=<0.05
Chronic administration of ouabain activates the brain renin-angiotensin system, leading to hypertension and sympathetic hyperactivity, which can be prevented by central AT1 receptor blockade.
Huang et al. (1999) studied Hypertension. Ouabain with or without losartan vs. Control rats was evaluated on Resting mean arterial pressure (p=<0.05). Chronic administration of ouabain in Wistar rats significantly increased resting mean arterial pressure compared to controls (111 vs 93 mm Hg; P<0.05), which was prevented by concomitant losartan.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: